Literature DB >> 22455929

Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding.

Zhen Xia1, Tien Huynh, Seung-gu Kang, Ruhong Zhou.   

Abstract

Antibodies binding to conserved epitopes can provide a broad range of neutralization to existing influenza subtypes and may also prevent the propagation of potential pandemic viruses by fighting against emerging strands. Here we propose a computational framework to study structural binding patterns and detailed molecular mechanisms of viral surface glycoprotein hemagglutinin (HA) binding with a broad spectrum of neutralizing monoclonal antibody fragments (Fab). We used rigorous free-energy perturbation (FEP) methods to calculate the antigen-antibody binding affinities, with an aggregate underlying molecular-dynamics simulation time of several microseconds (∼2 μs) using all-atom, explicit-solvent models. We achieved a high accuracy in the validation of our FEP protocol against a series of known binding affinities for this complex system, with <0.5 kcal/mol errors on average. We then introduced what to our knowledge are novel mutations into the interfacial region to further study the binding mechanism. We found that the stacking interaction between Trp-21 in HA2 and Phe-55 in the CDR-H2 of Fab is crucial to the antibody-antigen association. A single mutation of either W21A or F55A can cause a binding affinity decrease of ΔΔG > 4.0 kcal/mol (equivalent to an ∼1000-fold increase in the dissociation constant K(d)). Moreover, for group 1 HA subtypes (which include both the H1N1 swine flu and the H5N1 bird flu), the relative binding affinities change only slightly (< ±1 kcal/mol) when nonpolar residues at the αA helix of HA mutate to conservative amino acids of similar size, which explains the broad neutralization capability of antibodies such as F10 and CR6261. Finally, we found that the hydrogen-bonding network between His-38 (in HA1) and Ser-30/Gln-64 (in Fab) is important for preserving the strong binding of Fab against group 1 HAs, whereas the lack of such hydrogen bonds with Asn-38 in most group 2 HAs may be responsible for the escape of antibody neutralization. These large-scale simulations may provide new insight into the antigen-antibody binding mechanism at the atomic level, which could be essential for designing more-effective vaccines for influenza.
Copyright © 2012 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22455929      PMCID: PMC3309282          DOI: 10.1016/j.bpj.2012.01.043

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  58 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

Review 2.  Protein structural transitions and their functional role.

Authors:  Martin Karplus; Yi Qin Gao; Jianpeng Ma; Arjan van der Vaart; Wei Yang
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2005-02-15       Impact factor: 4.226

3.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

4.  Random walk in orthogonal space to achieve efficient free-energy simulation of complex systems.

Authors:  Lianqing Zheng; Mengen Chen; Wei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

5.  Single mutation induced H3N2 hemagglutinin antibody neutralization: a free energy perturbation study.

Authors:  Ruhong Zhou; Payel Das; Ajay K Royyuru
Journal:  J Phys Chem B       Date:  2008-12-11       Impact factor: 2.991

6.  Calculation of protein-ligand binding free energy by using a polarizable potential.

Authors:  Dian Jiao; Pavel A Golubkov; Thomas A Darden; Pengyu Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

7.  Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.

Authors:  James Stevens; Adam L Corper; Christopher F Basler; Jeffery K Taubenberger; Peter Palese; Ian A Wilson
Journal:  Science       Date:  2004-02-05       Impact factor: 47.728

8.  Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Authors:  Iain Stephenson; Jane Democratis; Angie Lackenby; Teresa McNally; James Smith; Manish Pareek; Joanna Ellis; Alison Bermingham; Karl Nicholson; Maria Zambon
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

9.  Hydrophobic collapse in multidomain protein folding.

Authors:  Ruhong Zhou; Xuhui Huang; Claudio J Margulis; Bruce J Berne
Journal:  Science       Date:  2004-09-10       Impact factor: 47.728

10.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Authors:  Mark Throsby; Edward van den Brink; Mandy Jongeneelen; Leo L M Poon; Philippe Alard; Lisette Cornelissen; Arjen Bakker; Freek Cox; Els van Deventer; Yi Guan; Jindrich Cinatl; Jan ter Meulen; Ignace Lasters; Rita Carsetti; Malik Peiris; John de Kruif; Jaap Goudsmit
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

View more
  14 in total

Review 1.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

2.  Molecular dynamics analysis of antibody recognition and escape by human H1N1 influenza hemagglutinin.

Authors:  Pek Ieong; Rommie E Amaro; Wilfred W Li
Journal:  Biophys J       Date:  2015-06-02       Impact factor: 4.033

3.  Theoretical studies of the interaction between influenza virus hemagglutinin and its small molecule ligands.

Authors:  Deshou Song; Hanhong Xu; Shuwen Liu
Journal:  J Mol Model       Date:  2013-11-21       Impact factor: 1.810

4.  An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.

Authors:  Runming Li; Deshou Song; Zhibo Zhu; Hanhong Xu; Shuwen Liu
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

5.  Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains.

Authors:  Le Cong; Ruhong Zhou; Yu-Chi Kuo; Margaret Cunniff; Feng Zhang
Journal:  Nat Commun       Date:  2012-07-24       Impact factor: 14.919

6.  Selecting vaccine strains for H3N2 human influenza A virus.

Authors:  Yoshiyuki Suzuki
Journal:  Meta Gene       Date:  2015-04-08

7.  Bio-mimicking of proline-rich motif applied to carbon nanotube reveals unexpected subtleties underlying nanoparticle functionalization.

Authors:  Yuanzhao Zhang; Camilo A Jimenez-Cruz; Jian Wang; Bo Zhou; Zaixing Yang; Ruhong Zhou
Journal:  Sci Rep       Date:  2014-11-27       Impact factor: 4.379

8.  Longitudinal Surveillance of Porcine Rotavirus B Strains from the United States and Canada and In Silico Identification of Antigenically Important Sites.

Authors:  Frances K Shepherd; Michael P Murtaugh; Fangzhou Chen; Marie R Culhane; Douglas G Marthaler
Journal:  Pathogens       Date:  2017-12-03

9.  Large domain motions in Ago protein controlled by the guide DNA-strand seed region determine the Ago-DNA-mRNA complex recognition process.

Authors:  Zhen Xia; Tien Huynh; Pengyu Ren; Ruhong Zhou
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

10.  The complex and specific pMHC interactions with diverse HIV-1 TCR clonotypes reveal a structural basis for alterations in CTL function.

Authors:  Zhen Xia; Huabiao Chen; Seung-gu Kang; Tien Huynh; Justin W Fang; Pedro A Lamothe; Bruce D Walker; Ruhong Zhou
Journal:  Sci Rep       Date:  2014-02-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.